NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors.

Evid Based Complement Alternat Med · 2013 · PMC3826324 · PMID 24285980

Europe PMC DOI

hedged sentences

0.0340

closest p · 0.7× alpha

0.0340

boldest claim

The sentences

a significant trendP = 0.034actually significant

When ANC maximum was measured, there was a significant trend ( P = 0.034) for the maximum ANC level achieved in stage II during cycle 1.

also in 6,248 other papers

showed a trendno p-value reported

ANC showed a trend to increase between baseline and cycle 2 in stage I dose escalation. 6% of patients showed partial response, 42% stable disease.

also in 33,481 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.